OXFORD, United Kingdom and HOUSTON, Jan. 29, 2026 /PRNewswire/ -- Optellum, a leader in AI-enabled lung cancer risk assessment, is pleased to announce its selection in a landmark NHS initiative that ...

Arcus Biosciences is discontinuing a phase 3 lung cancer trial it was conducting with Gilead Sciences. Arcus, an oncology company, said Monday it was ending the trial due to futility, meaning it doesn ...

The Azra AI logo represents the company’s commitment to transforming oncology care through intelligent automation and advanced AI solutions. Riverain Technologies company logo, a leader in AI-driven ...

GSK Plc and iTeos Therapeutics ended the development of an experimental lung cancer drug, the latest in a series of setbacks for a new generation of immunotherapy medicines. Interim analysis from two ...

The American Lung Association in New York is inviting the New York City community to unite as one mighty force for lung health by participating in the LUNG FORCE Walk on May 16. The 12th annual event ...

The American Lung Association in Pennsylvania is inviting the Greater Philadelphia community to unite as one mighty force for lung health by participating in the LUNG FORCE Walk – Philadelphia in ...

The survival rate for lung cancer is on the rise, as more Americans are getting earlier diagnoses that could save their lives. The American Lung Association released its eighth annual State of Lung ...

The American Lung Association has released the 2025 “State of Lung Cancer” report, which reveals that more needs to be done to end the burden of this devastating disease on families throughout the ...

Dr. Nathan Pennell and Dr. Cheryl Czerlanis discuss challenges in lung cancer screening and potential solutions to increase screening rates, including the use of AI to enhance risk prediction and ...

The MarketWatch News Department was not involved in the creation of this content. OXFORD, United Kingdom and HOUSTON, Jan. 29, 2026 /PRNewswire/ -- Optellum, a leader in AI-enabled lung cancer risk ...